Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PHA-794428 in Pediatric Growth Hormone Deficiency
NCT00314938Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Apr 2006
- Primary completion
- Nov 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 5
01
Overview
A Phase 2 trial of PHA-794428 in growth hormone deficiency (GHD), sponsored by Pfizer. Started Apr 2006; status: terminated.
02
Drugs
PHA-794428
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT00314938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00314938.